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Large cell neuroendocrine carcinomas of the colon are rare and represent only a small percentage of all colonic endocrine 
tumors. Here, we report a case of a colonic large cell neuroendocrine carcinomas concurrent with a colonic adenocarci-
noma. A 70-year-old man presented with acute abdominal pain. A spiral computed tomography scan of the abdomen re-
vealed eccentric wall thickening on the ascending colon. An explorative laparotomy and a right hemicolectomy were per-
formed. Grossly, two separated masses were observed in the proximal ascending colon. One was a 7.4 × 5.1 cm ulcerative 
fungating lesion, and the other was a 2.8 × 1.9 cm polypoid lesion. Microscopically, the ulcerative fungating lesion showed 
a well-differentiated neuroendocrine morphology with necrosis and increased mitosis. Most of the tumor cells had large, 
vesicular nuclei with eosinophilic nucleoli, variable amounts of eosinophilic cytoplasm, and immunoreactivity for chro-
mogranin A and synaptophysin. The polypoid lesion was a well-differentiated adenocarcinoma that had invaded the sub-
mucosa. We diagnosed these lesions as a concurrent large cell neuroendocrine carcinoma and an adenocarcinoma of the 
ascending colon.
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composed of an adenocarcinoma and a well-differentiated neuro-
endocrine neoplasm (carcinoid) or an adenoma and a carcinoid. 
A combination of a colorectal LCNEC and a colorectal adenocar-
cinoma is extremely rare, and only three cases have been reported 
[3-5]. Here, we present a rare case of a colonic concurrent tumor 
involving a LCNEC and an adenocarcinoma.
CASE REPORT
A 70-year-old man presented with acute abdominal pain lasting 
several hours. The past history was unremarkable. Physical exam-
ination revealed direct tenderness and rebound tenderness on the 
entire abdomen. The complete blood cell count showed an increased 
leukocytes (16,900/μL). Contrast-enhanced computed tomogra-
phy (CT) scans revealed eccentric wall thickening with mucosal 
enhancement of the proximal ascending colon (Fig. 1A). There 
were multiple air bubbles at the pericolic area, suggestive of bowel 
perforation. The levels of carcinoembryonic antigen and carbohy-
drate antigen 19-9 were within normal limits. The patient under-
went an emergency explorative laparotomy and a right hemico-
lectomy.
INTRODUCTION 
The current World Health Organization histologic classification 
of colorectal endocrine tumors includes well-differentiated neu-
roendocrine neoplasms, well-differentiated neuroendocrine car-
cinomas, and poorly-differentiated neuroendocrine carcinomas 
[1]. Neuroendocrine carcinomas of the colon and rectum are rare, 
representing 0.1-3.9% of colorectal cancers [2]. Furthermore, large 
cell neuroendocrine carcinomas (LCNECs) of the colon are ex-
tremely rare, representing 0.25% of colorectal cancers [2]. In the 
colon and the rectum, most concurrent tumors are those that are 
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Macroscopically, the cecal wall showed necrotic change with per-
foration through which fecal materials had leaked. The main co-
lonic lesion was located in the middle of ascending colon, causing 
near-complete obstruction of the lumen, and was composed of 
Fig. 1. (A) Contrast-enhanced computed tomography scan reveals eccentric wall thickening with mucosal enhancement of the proximal ascend-
ing colon (arrow). (B) Gross finding of the colonic lesion shows two separated masses. One is an ulcerative fungating mass (black arrows), and 
the other is a polypoid mass (arrowheads). There are several sessile polypoid lesions in the adjacent mucosa (white arrows).  
A B
Fig. 2. (A) Ulcerative fungating mass is separated abruptly from the normal colonic mucosa and shows a trabecular growth pattern (H&E, × 40). 
(B) It also shows nests and rosettes with comedo-type necrosis (H&E, × 100). (C) Some tumor cells reveal an individually infiltrative or an In-
dian file-like arrangement (H&E, × 200). (D) Tumor cells are arranged in rosettes and had large, vesicular nuclei with prominent eosinophilic 
nucleoli and eosinophilic cytoplasm (H&E, × 400). (E) The polypoid mass is composed of irregularly branching tubules and invades the sub-
mucosa (H&E, × 40). (F) The histologic features of the metastatic lymph nodes are similar to those of colonic large cell neuroendocrine carci-
noma (H&E, × 20).  
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two separated masses. One was a 7.4 × 5.1 cm fungating mass with 
ulceration in the center (Fig. 1B, black arrows). The cut surface re-
vealed a white-gray color, solid, poorly demarcated mass with fo-
cal necrosis. The other was a 2.8 × 1.9 cm polypoid mass (Fig. 1B, 
arrowheads), and it was located about 1 cm distally apart from the 
ulcerative fungating mass. Several sessile polypoid lesions measur-
ing less than 0.5 cm were also detected (Fig. 1B, white arrows). In 
addition to the right colon specimen, 29 resected regional lymph 
nodes were submitted.
Microscopically, the ulcerative fungating mass was separated 
abruptly from the normal colonic mucosa (Fig. 2A). It involved 
from the mucosa to the pericolic adipose tissue and showed well-
differentiated neuroendocrine morphology, such as nests, trabec-
ulae, acini and rosettes (Fig. 2B). A focal area of tumor cells with 
an individually infiltrative or an Indian file-like arrangement was 
noted (Fig. 2C). The majority of the tumor cells had large, vesicular 
nuclei with prominent eosinophilic nucleoli and variable amounts 
of eosinophilic cytoplasm (Fig. 2D). There were commedo-type 
necrosis, apoptotic bodies and high mitotic figures (10/10 HPF). 
The polypoid mass was a well-differentiated adenocarcinoma that 
was mainly composed of irregularly branching tubules and that 
had invaded the submucosa (Fig. 2E). Adjacent sessile polypoid 
lesions were hyperplastic polyps. Regional lymph node metastasis 
was detected in 11 out of 29 lymph nodes.
The histologic features were similar to those of colonic LCNEC 
(Fig. 2F). The tumor cells of the ulcerative fungating mass had peri-
nuclear, dot-like or cytoplasmic immunoreactivity for chromo-
granin A (Fig. 3A) and synaptophysin. On the other hand, the tu-
mor cells of the polypoid mass had no immunoreactivity for chro-
mogranin A (Fig. 3B) and synaptophysin. Both the tumor cells of 
the ulcerative fungating mass and of the polypoid mass had im-
munoreactivity for CK20 (Fig. 3C, D). Paraffin-embedded tissue 
samples for immunohistochemistry were provided by Chonbuk 
National University Hospital, a member of the National Biobank 
of Korea, which is supported by the Ministry of Health, Welfare 
and Family Affairs. We diagnosed these lesions as a concurrent 
LCNEC and adenocarcinoma of the ascending colon. Though we 
recommended adjuvant chemotherapy with the FOLFOX (Lecov-
orin, 5-FU, Exolatin) regimen after a right hemicolectomy, the pa-
tient rejected our suggestion.
DISCUSSION
Neuroendocrine tumors are rare neoplasms originating from the 
neuroendocrine system. They are classified into three groups: 1) 
well-differentiated neuroendocrine tumors showing benign behav-
ior or uncertain malignant potential (carcinoid), 2) well-differen-
tiated neuroendocrine carcinomas, which are characterized by low-
grade malignancy (malignant carcinoid) and 3) poorly differenti-
ated, usually small cell, neuroendocrine carcinomas of high-grade 
malignancy [1]. Most neuroendocrine tumors of the colon and the 
rectum are carcinoids. Well-differentiated neuroendocrine carci-
nomas are aggressive lesions and represent poorly-differentiated 
forms of carcinoid tumors with increased mitotic activity and ab-
sent or limited extent of necrosis.
The LCNEC is a newly defined high-grade malignant tumor   
entity of a non-small-cell-type neuroendocrine tumor, which is 
well established in pulmonary neuroendocrine tumors. A colonic 
LCNEC is a rare malignant neoplasm composed of large cells hav-
ing organoid, nesting, trabecular, rosette-like and palisading pat-
terns that suggest neuroendocrine differentiation. Tumor cells are 
generally in polygonal or oval shapes and show hyperchromatic or 
vesicular nuclei with prominent nucleoli and slightly eosinophilic 
cytoplasm with ill-defined cellular boundaries [1]. In contrast to 
small-cell carcinomas, the cytoplasm is more abundant, nuclei are 
more vesicular, and nucleoli are prominent.
Among colonic neuroendocrine tumors, 48% of the cases arise 
in the cecum, 16% in the ascending colon, 6% in the transverse 
colon, 11% in the descending colon, and 13% in the sigmoid co-
lon. Bernick et al. [2] reported that 0.6% of patients with colorec-
tal cancer were affected by neuroendocrine carcinomas and 0.2% 
by LCNECs. Most LCNECs located in the rectum and the cecum 
present in an advanced stage.
Colorectal LCNECs can be confirmed by immunohistochemis-
try and electron microscopy as long as a microscopic neuroendo-
crine morphology is present. However, the diagnoses of colorectal 
LCNECs are often too difficult because colorectal carcinomas fre-
quently exhibit neuroendocrine differentiation in 20-50% of cases, 
and neuroendocrine differentiation is more frequent in midgut-
Fig. 3. (A) The tumor cells of the ulcerative fungating mass have peri-
nuclear, dot-like or cytoplasmic immunoreactivity for chromogranin 
A (× 200). (B) The tumor cells of the polypoid mass have no immu-
noreactivity for chromogranin A (× 200). Note the immunoreactive 
endocrine cells in the glands as an internal positive control. (C) The 
tumor cells of the ulcerative fungating mass have strong cytoplasmic 
immunoreactivity for CK20 (× 100). (D) The tumor cells of the pol-
ypoid mass have cytoplasmic immunoreactivity for CK20 (× 100).
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derived carcinomas than in those of hindgut origin [6, 7]. There-
fore, the most important issue is to distinguish colorectal LCNECs 
from other colorectal carcinomas with neuroendocrine differenti-
ation. In the present case, a definite neuroendocrine morphology 
was recognized even though a focal area of vague, undifferentiated 
morphology existed. We believe that the recognition of an organ-
oid architecture is a good initial indication of the presence of a 
colorectal LCNEC and that a subsequent immunohistochemical 
stain may possibly contribute to a differential diagnosis. In immu-
nohistochemical staining, LCNECs express cytokeratins mimick-
ing poorly-differentiated adenocarcinomas. However, in contrast 
to poorly-differentiated adenocarcinomas, LCNECs express neu-
roendocrine markers.
Colorectal neruendocrine tumors are associated with secondary 
primary tumors, including both adenocarcinomas and other car-
cinoid tumors, in other sites, particularly in the GI tract. The over-
all incidence of secondary primary tumors ranges from 3% to 15% 
[8, 9]. LCNECs may be associated with an adjacent adenoma or     
a conventional adenocarcinoma. A combination of a colorectal 
LCNEC and a colorectal adenocarcinoma has only been reported 
in three cases (Table 1) [3-5]. Two of them involved a mixed tumor 
of either composite or collision type whereas the other involved a 
synchronous tumor as in the present case.
The precise pathogenesis of secondary primary tumors in pa-
tients with established neuroendocrine tumors remains unclear. 
One proposed hypotheses is the field effect, stimulated growth of 
neuroendocrine tumor cells and secondary primary tumor cells 
caused by common carcinogens. Another proposed hypothesis is 
the stem cell theory, which relates the potency of various differen-
tiations to several tumor types [10]. However, these hypotheses 
seem unlikely because a significant percentage of second primary 
malignancies occur in the genitourinary tract or even at more dis-
tant sites. The other proposed hypothesis is a common genetic al-
teration that predisposes an individual to the development of neu-
roendocrine tumors and second primary tumors. In addition, Kato 
et al. [11] reported a CK20 positive LCNEC of the colon and sug-
gested a possible link between a colorectal neuroendocrine carci-
noma and adenocarcinoma. This report is consistent with the im-
munohistochemical findings in our case, where the patient had 
an advanced stage of LCNEC and a simultaneous early-stage ade-
nocarcinoma in the ascending colon. However, more work is re-
quired to clarify the pathogenesis of a concurrent colorectal LCNEC 
and adenocarcinoma.
Although tumor size and microinvasion are major prognostic 
features in other GI neuroendocrine tumors, these features tend to 
be less useful in assessing the prognosis of colonic neuroendocrine 
tumors because most of these lesions exceed 2 cm in size and in-
volve the muscularis propria at the time of presentation [9]. Only 
16.6% of colonic neuroendocrine tumors less than 2 cm in size 
metastasize whereas 74% of those more than 2 cm in size metas-
tasize to the lymph nodes, liver, mesentery, peritoneum, pancreas, 
ureters, ovaries, and omentum [8]. Therefore, colonic neuroendo-
crine tumors can be treated by local excision if they are found when 
they are small; however, larger tumors should be treated aggres-
sively with a standard colonic resection and lymph node dissec-
tion. Mitotic rate, overall tumor grade, and histologic pattern all 
influence the survival for patients with colonic neuroendocrine 
tumors [9].
Colorectal LCNECs should be taken as a distinct histopathologic 
entity because they have a significantly worse prognosis than con-
ventional adenocarcinomas. This paper presented a rare example 
of two separated colonic tumors in a unique combination, namely, 
a concurrent LCNEC and adenocarcinoma of the ascending colon.
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